Tailong Pharmaceutical’s Announcement on Convening the 2025 Third Quarter Results and Cash Dividend Briefing Meeting
Securities code: 600222 Securities abbreviation: Tailong Pharmaceutical Announcement number: Lin 2025-056
Henan Tailong Pharmaceutical Co., Ltd.
About the convening of the third quarter results of 2025
Announcement and Cash Dividend Briefing Session
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Meeting time: November 07, 2025 (Friday) 11:00-12:00
Meeting location: Shanghai Stock Exchange SSE Roadshow Center (Website: https://roadshow.sseinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can log in to the homepage of the SSE Roadshow Center website from October 31, 2025 (Friday) to November 06 (Thursday) at 16:00 and click on the "Question Pre-Solicitation" column to ask questions, or send questions by email to the company's email address [email protected]. The company will answer questions of common concern to investors at the briefing.
Henan Tailong Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has released the company's "Third Quarter Report for 2025" and "Announcement of Profit Distribution Plan for the First Three Quarters of 2025" on October 30, 2025. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's operating results, financial status and profit distribution-related matters for the first three quarters of 2025, the company plans to release the report on November 07, 2025. The 2025 third quarter results and cash dividend briefing will be held from 11:00 to 12:00 on Friday (Friday) to communicate on issues of concern to investors.
1. Type of briefing session
This investor briefing will be held in an online interactive format. The company will interact and communicate with investors on matters related to operating results, financial status and profit distribution in the first three quarters of 2025, and answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting time: November 07, 2025 (Friday) 11:00-12:00
(2) Meeting location: Shanghai Securities Roadshow Center
(3) Meeting method: Shanghai Securities Roadshow Center online interaction
3. Participants
The personnel participating in this performance briefing are as follows: Chairman, independent directors, financial controller, and secretary of the board of directors (if there are special circumstances, the number of participants may be adjusted).
4. How to participate as an investor
(1) Investors can log in to the SSE Roadshow Center (https://roadshow.sseinfo.com/) via the Internet from 11:00-12:00 on November 7, 2025 (Friday) to participate in this performance briefing online. The company will answer investors’ questions in a timely manner.
(2) Investors can log in to the homepage of the SSE Roadshow Center website from October 31, 2025 (Friday) to November 06 (Thursday) at 16:00, click on the "Question Pre-Collection" column (https://roadshow.sseinfo.com/questionCollection.d o), select this event to ask questions according to the event time, or send questions to the company's mailbox by email [email protected], the company will answer questions of common concern to investors at the briefing.
5. Contact person and consultation method
Contact Department: Corporate Securities Department
Tel: 0371-67982194
Email: [email protected]
6. Other matters
After the investor briefing is held, investors can check the status and main content of the investor briefing through the SSE Roadshow Center (https://roadshow.sseinfo.com/).
Announcement is hereby made.
Board of Directors of Henan Tailong Pharmaceutical Co., Ltd.
October 30, 2025